Item 5. Other Information.
3K characters. Original on sec.gov ·
Item 5. Other Information.
(c) Insider Trading Arrangements
During the first quarter 2024, certain executive officers, as listed below, entered into Rule 10b5-1 trading arrangements that are intended to satisfy the affirmative defense of Rule 10b5-1(c). The plans provide for: i) the sale of a portion of the shares upon vesting pursuant to certain outstanding equity awards previously granted to the applicable executive officer, excluding any shares withheld by the company to satisfy tax withholding obligations (see the 2024 Proxy Statement for a description of the company’s equity compensation plans) and, ii) for certain executives, the sale and/or gift of additional shares held by the applicable executive, some of which may have been the result of a prior vesting event. Below are the details of each executive's Rule 10b5-1 trading arrangement:
| Executive Officer | Title | Date Entered | Date Expires* | Additional Shares | ||||||||||||||||||||||
| Jonathan S. Bauer | Chief Investment Officer | 3/18/2024 | 9/3/2024 | 2,047 | ||||||||||||||||||||||
| Steven A. Broz | Chief Information Officer | 1/26/2024 | 11/1/2024 | 16,511 | ||||||||||||||||||||||
| Susan Patricia Griffith | President and Chief Executive Officer | 2/28/2024 | 2/28/2025 | 13,359 | ||||||||||||||||||||||
| Lori Niederst | Customer Relationship Management President | 2/28/2024 | 12/31/2024 | 0 | ||||||||||||||||||||||
| Andrew J. Quigg | Chief Strategy Officer | 1/25/2024 | 2/3/2025 | 0 | ||||||||||||||||||||||
| John P. Sauerland | Vice President and Chief Financial Officer | 2/28/2024 | 2/28/2025 | 20,000 |
- subject to the plan’s earlier expiration or completion in accordance with its terms.
Additional Information
President and CEO Susan Patricia Griffith’s quarterly letter to shareholders is included as Exhibit 99 to this Quarterly Report on Form 10-Q and in our online shareholders’ report located on our investor relations website at: investors.progressive.com/financials.
Previous: Item 1A. Risk Factors. · Next: Item 6. Exhibits.